CRON
Cronos Group Inc.·Healthcare
2.58
1.176%(+0.03)
Market ClosedLast Updated: — ET
52W L: $1.6952W H: $3.43
CRON NEWS
marijuanastocks.com
2d ago
3 Canadian Cannabis Stocks Ready for Potential Breakouts in April 2026
The Canadian cannabis sector continues to evolve in 2026, even as volatility remains elevated. Total Canadian cannabis sales have steadily increased in recent years, showing consistent demand growth. However, pricing pressure and competition continue to challenge margins across the industry. Still, leading companies are adapting through international expansion, scale in retail, and diversification. As a result, investors are closely watching key names for potential upside during sector recoveries.
marijuanastocks.com
Mar 27
Top Canadian Marijuana Stocks To Watch This Month For Better Trading
The cannabis industry has made a tremendous impact on the world. From being once a taboo subject to now a well-respected and much more accepted industry. Even the thought of what may happen to a legal operator could shape the way marijuana stock investors think. At one point during the green rush, the fear of what could happen with no federal reform would shift how the market reacted. But as of 2026, those fears and worries have calmed down a lot.
zacks.com
Mar 26
Cannabis Operator CRON Rises 46% in a Year: Time to Buy, Sell or Hold?
Shares of Cronos Group CRON have staged a strong recovery over the past year. The Canada-based cannabis operator's shares have risen 46% in the said time frame, significantly outperforming the industry, as shown in the chart below.
seekingalpha.com
Mar 25
Cronos Group Inc. (CRON:CA) Presents at The 38th Annual Roth Conference Transcript
Cronos Group Inc. (CRON:CA) Presents at The 38th Annual Roth Conference Transcript
marijuanastocks.com
Mar 10
Canadian Cannabis Stocks to Watch in March 2026 as Global Legalization Expands
The global cannabis industry continues evolving as legalization slowly expands across multiple regions. Investors remain focused on companies positioned for long-term growth. Canadian cannabis producers still play a major role in this global expansion.
defenseworld.net
Mar 1
Cronos Group Q4 Earnings Call Highlights
Cronos Group (NASDAQ: CRON) reported what executives described as a record year in 2025, with organic net revenue growth of 25% and record results for quarterly and full-year net revenue, full-year gross profit, and adjusted EBITDA. Management pointed to strong consumer demand in Canada, continued expansion in Israel, and growing contributions from other international markets as
